These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12183652)

  • 21. Ligand-directed serotonin 5-HT
    Felsing DE; Canal CE; Booth RG
    Eur J Pharmacol; 2019 Apr; 848():131-139. PubMed ID: 30689993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Life Sci; 1990; 47(22):2009-19. PubMed ID: 2273941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homologous desensitization of muscarinic cholinergic, histaminergic, adrenergic, and serotonergic receptors coupled to phospholipase C in cerebellar granule cells.
    Dillon-Carter O; Chuang DM
    J Neurochem; 1989 Feb; 52(2):598-603. PubMed ID: 2536077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2.
    Werry TD; Gregory KJ; Sexton PM; Christopoulos A
    J Neurochem; 2005 Jun; 93(6):1603-15. PubMed ID: 15935077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
    Knauer CS; Campbell JE; Chio CL; Fitzgerald LW
    Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):461-71. PubMed ID: 19057895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
    Westphal RS; Backstrom JR; Sanders-Bush E
    Mol Pharmacol; 1995 Aug; 48(2):200-5. PubMed ID: 7651352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Hydroxytryptamine receptor-mediated phosphoinositide hydrolysis in canine cultured tracheal smooth muscle cells.
    Yang CM; Yo YL; Hsieh JT; Ong R
    Br J Pharmacol; 1994 Mar; 111(3):777-86. PubMed ID: 8019756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of the serotonin 5-HT2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses.
    Backstrom JR; Price RD; Reasoner DT; Sanders-Bush E
    J Biol Chem; 2000 Aug; 275(31):23620-6. PubMed ID: 10816555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
    Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.
    van Hooft JA; Vijverberg HP
    Br J Pharmacol; 1996 Mar; 117(5):839-46. PubMed ID: 8851499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
    Herrick-Davis K; Grinde E; Niswender CM
    J Neurochem; 1999 Oct; 73(4):1711-7. PubMed ID: 10501219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis.
    Felder CC; Kanterman RY; Ma AL; Axelrod J
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2187-91. PubMed ID: 2315313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction.
    Roevens P; de Chaffoy de Courcelles D
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):775-82. PubMed ID: 7741708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
    Berg KA; Clarke WP; Sailstad C; Saltzman A; Maayani S
    Mol Pharmacol; 1994 Sep; 46(3):477-84. PubMed ID: 7935328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
    Acuña-Castillo C; Villalobos C; Moya PR; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jun; 136(4):510-9. PubMed ID: 12055129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.